• 1
    Siperko LM, Landis WJ 2001 Aspects of mineral structure in normally calcifying avian tendon. J Struct Biol 135:313320.
  • 2
    Yamauchi M 1996 Collagen: The major matrix molecule in mineralized tissues. In: AndersonJB, GarnerSC (eds.) Calcium and Phosphorus Nutrition in Health and Disease. CRC Press, Boca Raton, FL, USA, pp. 127145.
  • 3
    Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF 2002 Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 16:673680.
  • 4
    Young MF 2003 Bone matrix proteins: Their function, regulation, and relationship to osteoporosis. Osteoporos Int 14(Suppl 3):S35S42.
  • 5
    Yamauchi M, Uzawa K, Katz EP, Lopes M, Verdelis K, Cheng H 2000 Distribution of small keratan sulfate proteoglycans in predentin and dentin. In: GoldbergM, BoskeyA, RobinsonC (eds.) Chemistry and Biology of Mineralized Tissues. American Academy of Orthopaedic Surgeons, Rosemont, IL, USA, pp. 305310.
  • 6
    Iozzo RV 1997 The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32:141174.
  • 7
    Iozzo RV 1999 The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 274:1884318846.
  • 8
    Fisher LW, Termine JD, Dejter SW Jr, Whitson SW, Yanagishita M, Kimura JH, Hascall VC, Kleinman HK, Hassell JR, Nilsson B 1983 Proteoglycans of developing bone. J Biol Chem 258:65886594.
  • 9
    Bianco P, Fisher LW, Young MF, Termine JD, Robey PG 1990 Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:15491563.
  • 10
    Young MF, Bi Y, Ameye L, Chen XD 2002 Biglycan knockout mice: New models for musculoskeletal diseases. Glycoconj J 19:257262.
  • 11
    Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H 1995 Interaction of biglycan with type I collagen. J Biol Chem 270:27762783.
  • 12
    Boskey AL, Spevak L, Doty SB, Rosenberg L 1997 Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int 61:298305.
  • 13
    Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF 1998 Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20:7882.
  • 14
    Chen XD, Shi S, Xu T, Robey PG, Young MF 2002 Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res 17:331340.
  • 15
    Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF 2002 Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 17:11801189.
  • 16
    Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT 1999 Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893903.
  • 17
    Mochida Y, Duarte WR, Tanzawa H, Paschalis EP, Yamauchi M 2003 Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun 305:69.
  • 18
    Fisher LW, Stubbs JT III, Young MF 1995 Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl 266:6165.
  • 19
    Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25:402408.
  • 20
    Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ 1995 Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106–01 BSP). J Biol Chem 270:94209428.
  • 21
    Grzesik WJ, Kuzentsov SA, Uzawa K, Mankani M, Robey PG, Yamauchi M 1998 Normal human cementum-derived cells: Isolation, clonal expansion, and in vitro and in vivo characterization. J Bone Miner Res 13:15471554.
  • 22
    Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG 1997 Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:10591069.
  • 23
    Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG 1997 Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12:13351347.
  • 24
    Asahina I, Sampath TK, Hauschka PV 1996 Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222:3847.
  • 25
    Yamaguchi A, Komori T, Suda T 2000 Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21:393411.
  • 26
    Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:1729.
  • 27
    Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233241.
  • 28
    Karsenty G 2001 Central control of bone formation. Adv Nephrol Necker Hosp 31:119133.
  • 29
    Karsenty G 2001 Minireview: Transcriptional control of osteoblast differentiation. Endocrinology 142:27312733.
  • 30
    Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747754.
  • 31
    Gersbach CA, Byers BA, Pavlath GK, Garcia AJ 2004 Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp Cell Res 300:406417.
  • 32
    Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM 2003 BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309:689694.
  • 33
    Chen J, Shapiro HS, Sodek J 1992 Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7:987997.
  • 34
    Goldberg HA, Warner KJ, Stillman MJ, Hunter GK 1996 Determination of the hydroxyapatite-nucleating region of bone sialoprotein. Connect Tissue Res 35:385392.
  • 35
    Tye CE, Hunter GK, Goldberg HA 2005 Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction. J Biol Chem 280:1348713492.
  • 36
    Kasugai S, Nagata T, Sodek J 1992 Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro. J Cell Physiol 152:467477.
  • 37
    Kuznetsov SA, Riminucci M, Ziran N, Tsutsui TW, Corsi A, Calvi L, Kronenberg HM, Schipani E, Robey PG, Bianco P 2004 The interplay of osteogenesis and hematopoiesis: Expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J Cell Biol 167:11131122.
  • 38
    Chen XD, Fisher LW, Robey PG, Young MF 2004 The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J 18:948958.
  • 39
    ten Dijke P, Fu J, Schaap P, Roelen BA 2003 Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 85(Suppl 3):3438.
  • 40
    Moreno M, Munoz R, Aroca F, Labarca M, Brandan E, Larrain J 2005 Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. Embo J 24:13971405.